RNA nanomedicines: the next generation drugs?

Current Opinion in Biotechnology
Manu Smriti Singh, Dan Peer

Abstract

RNA therapeutics could represent the next generation personalized medicine. The variety of RNA molecules that can inhibit the expression of any mRNA using, for example, RNA interference (RNAi) strategies, or increase the expression of a given protein using modified mRNA together with new gene editing strategies open new avenues for manipulating the fate of diseased cells while leaving healthy cells untouched. In addition, these therapeutic RNA molecules can maximize the treatment of diseases and minimize its adverse effects. Yet, the promise of RNA therapeutics is hindered by the lack of efficient delivery strategies to selectively target these molecules into specific cells. Herein, we will focus on the challenges and opportunities of the delivery of therapeutic RNAi molecules into cancer cells with special emphasis on solid tumors. Solid tumors represent more than 80 percent of cancers and some are very challenging to treat, not merely due to physiological barriers but also since the tumor microenvironment (TME) is a complex milieu of accessory cells besides the cancerous cells. In this review, we will highlight various limiting factors to successful delivery, current clinical achievements and future outlook focusing on RNAi t...Continue Reading

References

Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·O BoussifJ P Behr
Jul 25, 2006·Nature Reviews. Cancer·Andrew I Minchinton, Ian F Tannock
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Dan PeerMotomu Shimaoka
Apr 11, 2007·The Journal of Pharmacology and Experimental Therapeutics·Dan LuJessie L-S Au
May 9, 2008·The New England Journal of Medicine·Robert S Kerbel
Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
May 26, 2009·Nature Biotechnology·Aly A KhanDebora S Marks
Mar 17, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gaurav SahayAlexander V Kabanov
Sep 15, 2010·Nature Reviews. Clinical Oncology·Rakesh K Jain, Triantafyllos Stylianopoulos
Dec 17, 2010·Nature Reviews. Cancer·Chad V PecotAnil K Sood
Jan 29, 2011·BMC Systems Biology·Giulia CuccatoDiego di Bernardo
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Sarah J ConleyMax S Wicha
Sep 15, 2012·Advanced Drug Delivery Reviews·Ala Daka, Dan Peer
Mar 29, 2013·The New England Journal of Medicine·Harry L A JanssenMichael R Hodges
May 9, 2013·Nature Communications·Younghun JungRussell S Taichman
Jun 25, 2013·Nature Biotechnology·Gaurav SahayDaniel G Anderson
Aug 30, 2013·The New England Journal of Medicine·Teresa CoelhoOle B Suhr
Sep 13, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tamara MartínezAna Isabel Jiménez
Oct 18, 2013·Nature Reviews. Cancer·Michael PickupHarold L Moses
Nov 10, 2013·Nature Medicine·Daniela F Quail, Johanna A Joyce
May 6, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joseph W Nichols, You Han Bae
May 13, 2014·Nature Nanotechnology·James E DahlmanDaniel G Anderson
Jun 4, 2014·The Journal of Clinical Investigation·Andreas HerrmannHua Yu
Aug 12, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·D Haussecker
Dec 21, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Iftikhar Ali KhawarHyo-Jeong Kuh
Jan 18, 2015·Trends in Biotechnology·João Conde, Natalie Artzi
Feb 11, 2015·Advanced Drug Delivery Reviews·Gulnihal OzcanGabriel Lopez-Berestein
Feb 24, 2015·Theranostics·Xu WuJulia Xiaojun Zhao
Mar 20, 2015·Drug Delivery and Translational Research·Dalit Landesman-Milo, Dan Peer
May 8, 2015·Cancer Metastasis Reviews·Dalit Landesman-MiloDan Peer
Jun 23, 2015·Advanced Healthcare Materials·Yujin SunWoo Kyung Moon
Aug 19, 2015·Nature Reviews. Genetics·Anders Wittrup, Judy Lieberman
Aug 21, 2015·Connective Tissue Research·Adriana AlbiniKatiuscia Dallaglio

❮ Previous
Next ❯

Citations

May 3, 2016·Current Opinion in Biotechnology·Mingqi XieMartin Fussenegger
Sep 25, 2016·Regulatory Toxicology and Pharmacology : RTP·Achim AignerAlan Poole
Mar 30, 2017·Pharmaceutical Development and Technology·Noha G MorsiMahmoud Elsabahy
Jul 14, 2017·Nanomedicine·Geoffrey A PieterszKarlheinz Peter
Sep 21, 2018·Expert Opinion on Drug Delivery·Mariana MagalhãesFrancisco Veiga
Dec 7, 2018·Biological & Pharmaceutical Bulletin·Yuya Hayashi, Hirofumi Jono
Sep 24, 2019·Journal of Biomolecular Structure & Dynamics·Vasily N DanilevichAndrey L Mulyukin
Dec 5, 2020·Advanced Healthcare Materials·Terence TieuAnna Cifuentes-Rius
Nov 7, 2019·Chemistry and Physics of Lipids·Marcel ScheidelerRuth Prassl
Jan 8, 2017·Biomaterials·Leoni A Kunz-SchughartSuman Pokhrel
Apr 17, 2020·Advanced Drug Delivery Reviews·Nuphar VeigaDan Peer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.